Company / PP&E (Net)
Immuneering Corp PP&E (Net) History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.4M
FY2023
5-year range
$807.2K / $1.4M
FY2021-FY2023
Trend
+2.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $807,223 to $1M over the past 2 years.
Based on SEC 10-K filings.
$1M in FY2023.
Improved from $807,223 to $1M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, pp&e (net) increased 2.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2023 | $1.4M | +2.3% |
| FY2022 | $1.4M | +69.7% |
| FY2021 | $807.2K | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026